1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted

2. Executive Summary
2.1. Market Snapshot: Global PARP Inhibitor Biomarkers Market
2.2. Global PARP Inhibitor Biomarkers Market, By Product, 2025 (US$ Million)
2.3. Global PARP Inhibitor Biomarkers Market, By Service, 2025 (US$ Million)
2.4. Global PARP Inhibitor Biomarkers Market, By Technology, 2025 (US$ Million)
2.5. Global PARP Inhibitor Biomarkers Market, By Application, 2025 (US$ Million)
2.6. Global PARP Inhibitor Biomarkers Market, By End use, 2025 (US$ Million)
2.7. Global PARP Inhibitor Biomarkers Market, By Geography, 2025 (US$ Million)
2.8. Attractive Investment Proposition by Geography, 2025

3. PARP Inhibitor Biomarkers Market: Competitive Analysis
3.1. Market Positioning of Key PARP Inhibitor Biomarkers Market Vendors
3.2. Strategies Adopted by PARP Inhibitor Biomarkers Market Vendors

4. PARP Inhibitor Biomarkers Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global PARP Inhibitor Biomarkers Market Value, 2024 - 2034, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. Porter's Five Force Model
4.5.1. Supplier Power
4.5.2. Buyer Power
4.5.3. Threat Of Substitutes
4.5.4. Threat Of New Entrants
4.5.5. Competitive Rivalry
4.6. PESTEL Analysis
4.6.1. Political Landscape
4.6.2. Economic Landscape
4.6.3. Social Landscape
4.6.4. Technology Landscape
4.6.5. Environmental Landscape
4.6.6. Legal Landscape

5. PARP Inhibitor Biomarkers Market: By Product, 2024-2034, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2025 Versus 2034
5.3. Market Segmentation
5.3.1. Kits
5.3.2. Assays

6. PARP Inhibitor Biomarkers Market: By Service, 2024-2034, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2025 Versus 2034
6.3. Market Segmentation
6.3.1. Breast cancer gene (BRCA) 1 & 2 testing 
6.3.2. Homologous recombination deficiency (HRD) testing 
6.3.3. Homologous recombination repair (HRR) testing
6.3.4. Other services

7. PARP Inhibitor Biomarkers Market: By Technology, 2024-2034, USD (Million)
7.1. Market Overview
7.2. Growth & Revenue Analysis: 2025 Versus 2034
7.3. Market Segmentation
7.3.1. Next-generation sequencing
7.3.2. Polymerase Chain Reaction
7.3.3. Immunohistochemistry
7.3.4. In situ hybridization
7.3.5. other technologies

8. PARP Inhibitor Biomarkers Market: By Application, 2024-2034, USD (Million)
8.1. Market Overview
8.2. Growth & Revenue Analysis: 2025 Versus 2034
8.3. Market Segmentation
8.3.1. Breast cancer
8.3.2. Ovarian cancer
8.3.3. Pancreatic cancer
8.3.4. Prostate cancer
8.3.5. Other applications 

9. PARP Inhibitor Biomarkers Market: By End use, 2024-2034, USD (Million)
9.1. Market Overview
9.2. Growth & Revenue Analysis: 2025 Versus 2034
9.3. Market Segmentation
9.3.1. Hospitals and clinics
9.3.2. Diagnostic laboratories
9.3.3. Academic and research institutes
9.3.4. Other end users

10. North America PARP Inhibitor Biomarkers Market, 2024-2034, USD (Million)
10.1. Market Overview
10.2. PARP Inhibitor Biomarkers Market: By Product, 2024-2034, USD (Million)
10.3. PARP Inhibitor Biomarkers Market: By Service, 2024-2034, USD (Million)
10.4. PARP Inhibitor Biomarkers Market: By Technology, 2024-2034, USD (Million)
10.5. PARP Inhibitor Biomarkers Market: By Application, 2024-2034, USD (Million)
10.6. PARP Inhibitor Biomarkers Market: By End use, 2024-2034, USD (Million)
10.7. PARP Inhibitor Biomarkers Market: By Region, 2024-2034, USD (Million)
10.7.1.North America
10.7.1.1. U.S.
10.7.1.1.1. PARP Inhibitor Biomarkers Market: By Product, 2024-2034, USD (Million)
10.7.1.1.2. PARP Inhibitor Biomarkers Market: By Service, 2024-2034, USD (Million)
10.7.1.1.3. PARP Inhibitor Biomarkers Market: By Technology, 2024-2034, USD (Million)
10.7.1.1.4. PARP Inhibitor Biomarkers Market: By Application, 2024-2034, USD (Million)
10.7.1.1.5. PARP Inhibitor Biomarkers Market: By End use, 2024-2034, USD (Million)
10.7.1.2. Canada
10.7.1.2.1. PARP Inhibitor Biomarkers Market: By Product, 2024-2034, USD (Million)
10.7.1.2.2. PARP Inhibitor Biomarkers Market: By Service, 2024-2034, USD (Million)
10.7.1.2.3. PARP Inhibitor Biomarkers Market: By Technology, 2024-2034, USD (Million)
10.7.1.2.4. PARP Inhibitor Biomarkers Market: By Application, 2024-2034, USD (Million)
10.7.1.2.5. PARP Inhibitor Biomarkers Market: By End use, 2024-2034, USD (Million)
10.7.1.3. Rest of North America
10.7.1.3.1. PARP Inhibitor Biomarkers Market: By Product, 2024-2034, USD (Million)
10.7.1.3.2. PARP Inhibitor Biomarkers Market: By Service, 2024-2034, USD (Million)
10.7.1.3.3. PARP Inhibitor Biomarkers Market: By Technology, 2024-2034, USD (Million)
10.7.1.3.4. PARP Inhibitor Biomarkers Market: By Application, 2024-2034, USD (Million)
10.7.1.3.5. PARP Inhibitor Biomarkers Market: By End use, 2024-2034, USD (Million)

11. UK and European Union PARP Inhibitor Biomarkers Market, 2024-2034, USD (Million)
11.1. Market Overview
11.2. PARP Inhibitor Biomarkers Market: By Product, 2024-2034, USD (Million)
11.3. PARP Inhibitor Biomarkers Market: By Service, 2024-2034, USD (Million)
11.4. PARP Inhibitor Biomarkers Market: By Technology, 2024-2034, USD (Million)
11.5. PARP Inhibitor Biomarkers Market: By Application, 2024-2034, USD (Million)
11.6. PARP Inhibitor Biomarkers Market: By End use, 2024-2034, USD (Million)
11.7. PARP Inhibitor Biomarkers Market: By Region, 2024-2034, USD (Million)
11.7.1.UK and European Union
11.7.1.1. UK
11.7.1.1.1. PARP Inhibitor Biomarkers Market: By Product, 2024-2034, USD (Million)
11.7.1.1.2. PARP Inhibitor Biomarkers Market: By Service, 2024-2034, USD (Million)
11.7.1.1.3. PARP Inhibitor Biomarkers Market: By Technology, 2024-2034, USD (Million)
11.7.1.1.4. PARP Inhibitor Biomarkers Market: By Application, 2024-2034, USD (Million)
11.7.1.1.5. PARP Inhibitor Biomarkers Market: By End use, 2024-2034, USD (Million)
11.7.1.2. Germany
11.7.1.2.1. PARP Inhibitor Biomarkers Market: By Product, 2024-2034, USD (Million)
11.7.1.2.2. PARP Inhibitor Biomarkers Market: By Service, 2024-2034, USD (Million)
11.7.1.2.3. PARP Inhibitor Biomarkers Market: By Technology, 2024-2034, USD (Million)
11.7.1.2.4. PARP Inhibitor Biomarkers Market: By Application, 2024-2034, USD (Million)
11.7.1.2.5. PARP Inhibitor Biomarkers Market: By End use, 2024-2034, USD (Million)
11.7.1.3. Spain
11.7.1.3.1. PARP Inhibitor Biomarkers Market: By Product, 2024-2034, USD (Million)
11.7.1.3.2. PARP Inhibitor Biomarkers Market: By Service, 2024-2034, USD (Million)
11.7.1.3.3. PARP Inhibitor Biomarkers Market: By Technology, 2024-2034, USD (Million)
11.7.1.3.4. PARP Inhibitor Biomarkers Market: By Application, 2024-2034, USD (Million)
11.7.1.3.5. PARP Inhibitor Biomarkers Market: By End use, 2024-2034, USD (Million)
11.7.1.4. Italy
11.7.1.4.1. PARP Inhibitor Biomarkers Market: By Product, 2024-2034, USD (Million)
11.7.1.4.2. PARP Inhibitor Biomarkers Market: By Service, 2024-2034, USD (Million)
11.7.1.4.3. PARP Inhibitor Biomarkers Market: By Technology, 2024-2034, USD (Million)
11.7.1.4.4. PARP Inhibitor Biomarkers Market: By Application, 2024-2034, USD (Million)
11.7.1.4.5. PARP Inhibitor Biomarkers Market: By End use, 2024-2034, USD (Million)
11.7.1.5. France
11.7.1.5.1. PARP Inhibitor Biomarkers Market: By Product, 2024-2034, USD (Million)
11.7.1.5.2. PARP Inhibitor Biomarkers Market: By Service, 2024-2034, USD (Million)
11.7.1.5.3. PARP Inhibitor Biomarkers Market: By Technology, 2024-2034, USD (Million)
11.7.1.5.4. PARP Inhibitor Biomarkers Market: By Application, 2024-2034, USD (Million)
11.7.1.5.5. PARP Inhibitor Biomarkers Market: By End use, 2024-2034, USD (Million)
11.7.1.6. Rest of Europe
11.7.1.6.1. PARP Inhibitor Biomarkers Market: By Product, 2024-2034, USD (Million)
11.7.1.6.2. PARP Inhibitor Biomarkers Market: By Service, 2024-2034, USD (Million)
11.7.1.6.3. PARP Inhibitor Biomarkers Market: By Technology, 2024-2034, USD (Million)
11.7.1.6.4. PARP Inhibitor Biomarkers Market: By Application, 2024-2034, USD (Million)
11.7.1.6.5. PARP Inhibitor Biomarkers Market: By End use, 2024-2034, USD (Million)

12. Asia Pacific PARP Inhibitor Biomarkers Market, 2024-2034, USD (Million)
12.1. Market Overview
12.2. PARP Inhibitor Biomarkers Market: By Product, 2024-2034, USD (Million)
12.3. PARP Inhibitor Biomarkers Market: By Service, 2024-2034, USD (Million)
12.4. PARP Inhibitor Biomarkers Market: By Technology, 2024-2034, USD (Million)
12.5. PARP Inhibitor Biomarkers Market: By Application, 2024-2034, USD (Million)
12.6. PARP Inhibitor Biomarkers Market: By End use, 2024-2034, USD (Million)
12.7. PARP Inhibitor Biomarkers Market: By Region, 2024-2034, USD (Million)
12.7.1.Asia Pacific
12.7.1.1. China
12.7.1.1.1. PARP Inhibitor Biomarkers Market: By Product, 2024-2034, USD (Million)
12.7.1.1.2. PARP Inhibitor Biomarkers Market: By Service, 2024-2034, USD (Million)
12.7.1.1.3. PARP Inhibitor Biomarkers Market: By Technology, 2024-2034, USD (Million)
12.7.1.1.4. PARP Inhibitor Biomarkers Market: By Application, 2024-2034, USD (Million)
12.7.1.1.5. PARP Inhibitor Biomarkers Market: By End use, 2024-2034, USD (Million)
12.7.1.2. Japan
12.7.1.2.1. PARP Inhibitor Biomarkers Market: By Product, 2024-2034, USD (Million)
12.7.1.2.2. PARP Inhibitor Biomarkers Market: By Service, 2024-2034, USD (Million)
12.7.1.2.3. PARP Inhibitor Biomarkers Market: By Technology, 2024-2034, USD (Million)
12.7.1.2.4. PARP Inhibitor Biomarkers Market: By Application, 2024-2034, USD (Million)
12.7.1.2.5. PARP Inhibitor Biomarkers Market: By End use, 2024-2034, USD (Million)
12.7.1.3. India
12.7.1.3.1. PARP Inhibitor Biomarkers Market: By Product, 2024-2034, USD (Million)
12.7.1.3.2. PARP Inhibitor Biomarkers Market: By Service, 2024-2034, USD (Million)
12.7.1.3.3. PARP Inhibitor Biomarkers Market: By Technology, 2024-2034, USD (Million)
12.7.1.3.4. PARP Inhibitor Biomarkers Market: By Application, 2024-2034, USD (Million)
12.7.1.3.5. PARP Inhibitor Biomarkers Market: By End use, 2024-2034, USD (Million)
12.7.1.4. Australia
12.7.1.4.1. PARP Inhibitor Biomarkers Market: By Product, 2024-2034, USD (Million)
12.7.1.4.2. PARP Inhibitor Biomarkers Market: By Service, 2024-2034, USD (Million)
12.7.1.4.3. PARP Inhibitor Biomarkers Market: By Technology, 2024-2034, USD (Million)
12.7.1.4.4. PARP Inhibitor Biomarkers Market: By Application, 2024-2034, USD (Million)
12.7.1.4.5. PARP Inhibitor Biomarkers Market: By End use, 2024-2034, USD (Million)
12.7.1.5. South Korea
12.7.1.5.1. PARP Inhibitor Biomarkers Market: By Product, 2024-2034, USD (Million)
12.7.1.5.2. PARP Inhibitor Biomarkers Market: By Service, 2024-2034, USD (Million)
12.7.1.5.3. PARP Inhibitor Biomarkers Market: By Technology, 2024-2034, USD (Million)
12.7.1.5.4. PARP Inhibitor Biomarkers Market: By Application, 2024-2034, USD (Million)
12.7.1.5.5. PARP Inhibitor Biomarkers Market: By End use, 2024-2034, USD (Million)
12.7.1.6. Rest of Asia Pacific
12.7.1.6.1. PARP Inhibitor Biomarkers Market: By Product, 2024-2034, USD (Million)
12.7.1.6.2. PARP Inhibitor Biomarkers Market: By Service, 2024-2034, USD (Million)
12.7.1.6.3. PARP Inhibitor Biomarkers Market: By Technology, 2024-2034, USD (Million)
12.7.1.6.4. PARP Inhibitor Biomarkers Market: By Application, 2024-2034, USD (Million)
12.7.1.6.5. PARP Inhibitor Biomarkers Market: By End use, 2024-2034, USD (Million)

13. Latin America PARP Inhibitor Biomarkers Market, 2024-2034, USD (Million)
13.1. Market Overview
13.2. PARP Inhibitor Biomarkers Market: By Product, 2024-2034, USD (Million)
13.3. PARP Inhibitor Biomarkers Market: By Service, 2024-2034, USD (Million)
13.4. PARP Inhibitor Biomarkers Market: By Technology, 2024-2034, USD (Million)
13.5. PARP Inhibitor Biomarkers Market: By Application, 2024-2034, USD (Million)
13.6. PARP Inhibitor Biomarkers Market: By End use, 2024-2034, USD (Million)
13.7. PARP Inhibitor Biomarkers Market: By Region, 2024-2034, USD (Million)
13.7.1.Latin America
13.7.1.1. Brazil
13.7.1.1.1. PARP Inhibitor Biomarkers Market: By Product, 2024-2034, USD (Million)
13.7.1.1.2. PARP Inhibitor Biomarkers Market: By Service, 2024-2034, USD (Million)
13.7.1.1.3. PARP Inhibitor Biomarkers Market: By Technology, 2024-2034, USD (Million)
13.7.1.1.4. PARP Inhibitor Biomarkers Market: By Application, 2024-2034, USD (Million)
13.7.1.1.5. PARP Inhibitor Biomarkers Market: By End use, 2024-2034, USD (Million)
13.7.1.2. Mexico
13.7.1.2.1. PARP Inhibitor Biomarkers Market: By Product, 2024-2034, USD (Million)
13.7.1.2.2. PARP Inhibitor Biomarkers Market: By Service, 2024-2034, USD (Million)
13.7.1.2.3. PARP Inhibitor Biomarkers Market: By Technology, 2024-2034, USD (Million)
13.7.1.2.4. PARP Inhibitor Biomarkers Market: By Application, 2024-2034, USD (Million)
13.7.1.2.5. PARP Inhibitor Biomarkers Market: By End use, 2024-2034, USD (Million)
13.7.1.3. Rest of Latin America
13.7.1.3.1. PARP Inhibitor Biomarkers Market: By Product, 2024-2034, USD (Million)
13.7.1.3.2. PARP Inhibitor Biomarkers Market: By Service, 2024-2034, USD (Million)
13.7.1.3.3. PARP Inhibitor Biomarkers Market: By Technology, 2024-2034, USD (Million)
13.7.1.3.4. PARP Inhibitor Biomarkers Market: By Application, 2024-2034, USD (Million)
13.7.1.3.5. PARP Inhibitor Biomarkers Market: By End use, 2024-2034, USD (Million)

14. Middle East and Africa PARP Inhibitor Biomarkers Market, 2024-2034, USD (Million)
14.1. Market Overview
14.2. PARP Inhibitor Biomarkers Market: By Product, 2024-2034, USD (Million)
14.3. PARP Inhibitor Biomarkers Market: By Service, 2024-2034, USD (Million)
14.4. PARP Inhibitor Biomarkers Market: By Technology, 2024-2034, USD (Million)
14.5. PARP Inhibitor Biomarkers Market: By Application, 2024-2034, USD (Million)
14.6. PARP Inhibitor Biomarkers Market: By End use, 2024-2034, USD (Million)
14.7. PARP Inhibitor Biomarkers Market: By Region, 2024-2034, USD (Million)
14.7.1.Middle East and Africa
14.7.1.1. GCC
14.7.1.1.1. PARP Inhibitor Biomarkers Market: By Product, 2024-2034, USD (Million)
14.7.1.1.2. PARP Inhibitor Biomarkers Market: By Service, 2024-2034, USD (Million)
14.7.1.1.3. PARP Inhibitor Biomarkers Market: By Technology, 2024-2034, USD (Million)
14.7.1.1.4. PARP Inhibitor Biomarkers Market: By Application, 2024-2034, USD (Million)
14.7.1.1.5. PARP Inhibitor Biomarkers Market: By End use, 2024-2034, USD (Million)
14.7.1.2. Africa
14.7.1.2.1. PARP Inhibitor Biomarkers Market: By Product, 2024-2034, USD (Million)
14.7.1.2.2. PARP Inhibitor Biomarkers Market: By Service, 2024-2034, USD (Million)
14.7.1.2.3. PARP Inhibitor Biomarkers Market: By Technology, 2024-2034, USD (Million)
14.7.1.2.4. PARP Inhibitor Biomarkers Market: By Application, 2024-2034, USD (Million)
14.7.1.2.5. PARP Inhibitor Biomarkers Market: By End use, 2024-2034, USD (Million)
14.7.1.3. Rest of Middle East and Africa
14.7.1.3.1. PARP Inhibitor Biomarkers Market: By Product, 2024-2034, USD (Million)
14.7.1.3.2. PARP Inhibitor Biomarkers Market: By Service, 2024-2034, USD (Million)
14.7.1.3.3. PARP Inhibitor Biomarkers Market: By Technology, 2024-2034, USD (Million)
14.7.1.3.4. PARP Inhibitor Biomarkers Market: By Application, 2024-2034, USD (Million)
14.7.1.3.5. PARP Inhibitor Biomarkers Market: By End use, 2024-2034, USD (Million)

15. Company Profile
15.1. Agilent Technologies (Company Overview, Financial Performance, Product Portfolio, Strategic Initiatives)
15.2. Ambry Genetics
15.3. Amoy Diagnostics
15.4. BPS Bioscience
15.5. EntroGen
15.6. Foundation Medicine
15.7. Guardant Health
15.8. Illumina Inc.
15.9. Invitae
15.10. Myriad Genetics
15.11. Pillar Biosciences
15.12. QIAGEN
15.13. Other Notable Players